N03AG04 vigabatrin
ATC group of level 5 – chemical substance · in plain English: medicines for epilepsy
This site has the patient leaflet or the SPC of 7 medicines in this group.
- 5 prescription only (POM)
Active substance: Vigabatrin – all medicines with this substance, also in combinations.
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N03 Antiepileptics 1,124 medicines
- N03A Antiepileptics 1,124 medicines
- N03AG Fatty acid derivatives, antiepileptics 62 medicines
- N03AG04 vigabatrin 7 medicines
- N03AG Fatty acid derivatives, antiepileptics 62 medicines
- N03A Antiepileptics 1,124 medicines
- N03 Antiepileptics 1,124 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Kigabeq 100 mg soluble tablets SPC | Prescription only (POM) |
| Kigabeq 500 mg soluble tablets SPC | Prescription only (POM) |
| Sabril 500 mg film-coated tablets | Prescription only (POM) |
| Sabril sachet 0.5 g | – |
| Sabril tablets 500 mg SPC | Prescription only (POM) |
| Vigabatrin MSN 500 mg granules for oral solution SPC | Prescription only (POM) |
| Vigabatrin Zydus Pharmaceuticals UK 100 mg/ml oral solution SPC | – |
Other groups of the same level
- N03AG01 valproic acid 52 medicines
- N03AG06 tiagabine 3 medicines
Other names of the ATC group
- Czech: N03AG04 Vigabatrin
- French: N03AG04 vigabatrine
- German: N03AG04 Vigabatrin
- Spanish: N03AG04 VIGABATRINA
- German: N03AG04 Vigabatrin
- Italian: N03AG04 VIGABATRIN
- Polish: N03AG04 WIGABATRYNA
- Turkish: N03AG04 vigabatrin
- Portuguese (Brazil): N03AG04 Vigabatrima
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N03AG04
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
